Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Neoadjuvant chemotherapy"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 53
Tytuł:
Exploring miRNA‑target gene profiles associated with drug resistance in patients with breast cancer receiving neoadjuvant chemotherapy.
Autorzy:
Kim MW; Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Moon S; Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Lee S; Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Lee H; Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Kim Y; Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Kim JY; Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Kim JY; Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Kim SI; Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2024 Feb 16; Vol. 27 (4), pp. 158. Date of Electronic Publication: 2024 Feb 16 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adaptive radiotherapy of locally advanced sigmoid colon cancer with intra‑fractional motion using the MRIdian system: A case report.
Autorzy:
Chiang CH; Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan, R.O.C.
Chao TY; Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan, R.O.C.
Huang MY; Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan, R.O.C.; Department of Radiation Oncology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80756, Taiwan, R.O.C.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2023 Sep 27; Vol. 26 (5), pp. 487. Date of Electronic Publication: 2023 Sep 27 (Print Publication: 2023).
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prognostic relevance of tumor‑infiltrating lymphocytes in residual tumor tissue from patients with triple‑negative breast cancer following neoadjuvant chemotherapy: A systematic review and meta‑analysis.
Autorzy:
Cao B; Department of Breast Diseases, Jiaxing Maternity and Child Health Care Hospital, Affiliated Women and Children's Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, P.R. China.
Zhang Z; Department of Breast Diseases, Jiaxing Maternity and Child Health Care Hospital, Affiliated Women and Children's Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, P.R. China.
Wang C; Department of Breast Diseases, Jiaxing Maternity and Child Health Care Hospital, Affiliated Women and Children's Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, P.R. China.
Lv X; Department of Breast Diseases, Jiaxing Maternity and Child Health Care Hospital, Affiliated Women and Children's Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2023 Aug 24; Vol. 26 (4), pp. 441. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predictors of successful neoadjuvant treatment in HER2‑positive breast cancer.
Autorzy:
Hännikäinen EN; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, FI-00029 Helsinki, Finland.
Mattson J; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, FI-00029 Helsinki, Finland.
Karihtala P; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, FI-00029 Helsinki, Finland.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2023 Aug 22; Vol. 26 (4), pp. 434. Date of Electronic Publication: 2023 Aug 22 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real‑world data indicated that neoadjuvant chemotherapy alone was associated with a higher risk of tumor recurrence in high‑risk breast cancer subgroup patients.
Autorzy:
Li Z; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, P.R. China.
Li Y; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, P.R. China.
Liu Y; Department of Breast Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, P.R. China.
Shang Y; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, P.R. China.
Zhou Y; Department of Breast Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, P.R. China.
Ji X; Department of Ultrasound, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, P.R. China.
Han H; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, P.R. China.
Du K; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, P.R. China.
Zhang J; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2023 Mar 30; Vol. 25 (5), pp. 193. Date of Electronic Publication: 2023 Mar 30 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lymph node response to neoadjuvant chemotherapy as an independent prognostic factor in gastric cancer.
Autorzy:
Wada Y; Department of Surgery, Tokushima University, Tokushima 770-8503, Japan.
Nishi M; Department of Surgery, Tokushima University, Tokushima 770-8503, Japan.
Yoshikawa K; Department of Surgery, Tokushima University, Tokushima 770-8503, Japan.
Takasu C; Department of Surgery, Tokushima University, Tokushima 770-8503, Japan.
Tokunaga T; Department of Surgery, Tokushima University, Tokushima 770-8503, Japan.
Nakao T; Department of Surgery, Tokushima University, Tokushima 770-8503, Japan.
Kashihara H; Department of Surgery, Tokushima University, Tokushima 770-8503, Japan.
Yoshimoto T; Department of Surgery, Tokushima University, Tokushima 770-8503, Japan.
Shimada M; Department of Surgery, Tokushima University, Tokushima 770-8503, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2022 Sep 28; Vol. 24 (5), pp. 415. Date of Electronic Publication: 2022 Sep 28 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical impact of remnant lymphatic invasion on the recurrence of esophageal squamous cell carcinoma after esophagectomy with neoadjuvant chemotherapy.
Autorzy:
Okuda S; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Ohuchida K; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Shindo K; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Moriyama T; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Kawata J; Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Tamura K; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Sada M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Nagayoshi K; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Mizuuchi Y; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Ikenaga N; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Nakata K; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Oda Y; Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Nakamura M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2022 Aug 11; Vol. 24 (4), pp. 337. Date of Electronic Publication: 2022 Aug 11 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Progress in neoadjuvant therapy for gastric cancer.
Autorzy:
Su PF; Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, P.R. China.
Yu JC; Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2022 Jun; Vol. 23 (6), pp. 172. Date of Electronic Publication: 2022 Apr 13.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Exosomal miRNA profiles of triple-negative breast cancer in neoadjuvant treatment.
Autorzy:
Sueta A; Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto 860-8556, Japan.
Fujiki Y; Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto 860-8556, Japan.
Goto-Yamaguchi L; Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto 860-8556, Japan.
Tomiguchi M; Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto 860-8556, Japan.
Yamamoto-Ibusuki M; Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto 860-8556, Japan.
Iwase H; Department of Breast Surgery, Kumamoto City Hospital, Kumamoto 862-8505, Japan.
Yamamoto Y; Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto 860-8556, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2021 Dec; Vol. 22 (6), pp. 819. Date of Electronic Publication: 2021 Oct 05.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
T-box 2 expression is a useful indicator of the response to neoadjuvant chemotherapy for patients with locally advanced uterine cervical squamous cell carcinoma.
Autorzy:
Inoue Y; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Fukuda T; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Nanno S; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Awazu Y; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Shimomura M; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Matsubara H; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Yamauchi M; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Yasui T; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Sumi T; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2021 Nov; Vol. 22 (5), pp. 755. Date of Electronic Publication: 2021 Aug 31.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
LACTB and LC3 could serve as potential biomarkers of gastric cancer to neoadjuvant chemotherapy with oxaliplatin plus S-1.
Autorzy:
Yang F; Department of Pathology, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.; School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.; Laboratory Department of Guizhou Cancer Hospital, Guiyang, Guizhou 550004, P.R. China.
Yan Z; Department of Gastrointestinal Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Nie W; School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Liu Z; Laboratory Department of Guizhou Cancer Hospital, Guiyang, Guizhou 550004, P.R. China.
Cheng X; Department of Gastrointestinal Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Wang W; Laboratory Department of Guizhou Cancer Hospital, Guiyang, Guizhou 550004, P.R. China.
Shao C; Laboratory Department of Guizhou Cancer Hospital, Guiyang, Guizhou 550004, P.R. China.
Fu G; Laboratory Department of Guizhou Cancer Hospital, Guiyang, Guizhou 550004, P.R. China.
Yu Y; Department of Pathology, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2021 Jun; Vol. 21 (6), pp. 470. Date of Electronic Publication: 2021 Apr 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
High expression levels of centromere protein A plus upregulation of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway affect chemotherapy response and prognosis in patients with breast cancer.
Autorzy:
Zhang S; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Xie Y; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Tian T; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Yang Q; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Zhou Y; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Qiu J; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Xu L; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Wen N; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Lv Q; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Du Z; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2021 May; Vol. 21 (5), pp. 410. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
Autorzy:
Shimomura M; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Fukuda T; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Awazu Y; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Nanno S; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Inoue Y; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Matsubara H; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Yamauchi M; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Yasui T; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Sumi T; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2021 Feb; Vol. 21 (2), pp. 150. Date of Electronic Publication: 2020 Dec 24.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer.
Autorzy:
Mizuno T; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.; The Jikei University Graduate School of Medicine, Tokyo 105-8461, Japan.
Kojima Y; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Yonemori K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Yoshida H; Department of Pathology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Sugiura Y; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Ohtake Y; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Okuma HS; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Nishikawa T; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Tanioka M; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Sudo K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Shimomura A; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Noguchi E; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Kato T; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Shimoi T; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Uno M; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Fujiwara Y; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Ohe Y; The Jikei University Graduate School of Medicine, Tokyo 105-8461, Japan.
Tamura K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2020 Dec; Vol. 20 (6), pp. 336. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expression of HIF-1α is a predictive marker of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer.
Autorzy:
Yan B; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Ma QF; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Tan WF; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Cai HN; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Li YL; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Zhou ZG; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Dai X; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Zhu FX; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Xiong YJ; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Xu M; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Guo YL; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Gao H; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Hu JB; Department of Pathology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Wu XF; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, Hubei 430070, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2020 Jul; Vol. 20 (1), pp. 841-849. Date of Electronic Publication: 2020 May 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Changes in the gene mutation profiles of circulating tumor DNA detected using CAPP-Seq in neoadjuvant chemotherapy-treated advanced ovarian cancer.
Autorzy:
Noguchi T; Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, Wakayama 641-0012, Japan.
Sakai K; Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
Iwahashi N; Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, Wakayama 641-0012, Japan.
Matsuda K; Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, Wakayama 641-0012, Japan.
Matsukawa H; Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, Wakayama 641-0012, Japan.
Yahata T; Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, Wakayama 641-0012, Japan.
Toujima S; Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, Wakayama 641-0012, Japan.
Nishio K; Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
Ino K; Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, Wakayama 641-0012, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2020 Apr; Vol. 19 (4), pp. 2713-2720. Date of Electronic Publication: 2020 Jan 28.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Association of serum levels of deoxyribose 1-phosphate and S-lactoylglutathione with neoadjuvant chemotherapy sensitivity in patients with gastric cancer: A metabolomics study.
Autorzy:
Wang D; Department of Gastrointestinal Surgery, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Li W; Department of Gastrointestinal Surgery, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Yin L; Research Institute of Translational Medicine, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Du Y; Department of Gastrointestinal Surgery, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Zhang S; Department of Gastrointestinal Surgery, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Suo J; Department of Gastrointestinal Surgery, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.; Jilin Province Key Laboratory of Bioinformatics for Gastrointestinal Tumor, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2020 Mar; Vol. 19 (3), pp. 2231-2242. Date of Electronic Publication: 2020 Jan 24.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Predictive value of immuno-inflammatory and nutritional measures modulated by neoadjuvant chemotherapy on the response of neoadjuvant chemotherapy and long-term outcomes in patients with esophageal cancer.
Autorzy:
Ishibashi Y; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Tsujimoto H; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Hiraki S; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Kouzu K; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Tsuchiya S; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Itazaki Y; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Yaguchi Y; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Horiguchi H; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Nomura S; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Ito N; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Shinto E; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Kishi Y; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Ueno H; Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2020 Jan; Vol. 19 (1), pp. 487-497. Date of Electronic Publication: 2019 Nov 19.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognosis and endocrine therapy selection for patients with low hormone receptor-positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in China.
Autorzy:
Ding Y; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Ding K; Department of Child Psychology, Zhejiang University Affiliated Mental Health Center, Hangzhou, Zhejiang 310013, P.R. China.
Yu K; Department of Thyroid Breast Surgery, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China.
Zou D; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Yang H; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
He X; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Mo W; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Yu X; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Ding X; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2019 Dec; Vol. 18 (6), pp. 6690-6696. Date of Electronic Publication: 2019 Nov 01.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience.
Autorzy:
Del Prete S; Division of Medical Oncology, 'San Giovanni Di Dio Hospital', ASL NA2NORD, I-80027 Naples, Italy.
Caraglia M; Department of Precision Medicine, University of Campania 'L. Vanvitelli', I-80138 Naples, Italy.
Luce A; Department of Precision Medicine, University of Campania 'L. Vanvitelli', I-80138 Naples, Italy.
Montella L; Division of Medical Oncology, 'San Giovanni Di Dio Hospital', ASL NA2NORD, I-80027 Naples, Italy.
Galizia G; Division of Gastrointestinal Tract Surgical Oncology, Department of Translational Medical Sciences, University of Campania 'L. Vanvitelli', I-80138 Naples, Italy.
Sperlongano P; Division of Gastrointestinal Tract Surgical Oncology, Department of Translational Medical Sciences, University of Campania 'L. Vanvitelli', I-80138 Naples, Italy.
Cennamo G; Division of Medical Oncology, 'San Giovanni Di Dio Hospital', ASL NA2NORD, I-80027 Naples, Italy.
Lieto E; Division of Gastrointestinal Tract Surgical Oncology, Department of Translational Medical Sciences, University of Campania 'L. Vanvitelli', I-80138 Naples, Italy.
Capasso E; Division of Medical Oncology, 'San Giovanni Di Dio Hospital', ASL NA2NORD, I-80027 Naples, Italy.
Fiorentino O; Pathologist Department, Medicina Futura Group, I-80011 Naples, Italy.
Aliberti M; Division of Medical Oncology, 'San Giovanni Di Dio Hospital', ASL NA2NORD, I-80027 Naples, Italy.
Auricchio A; Division of Gastrointestinal Tract Surgical Oncology, Department of Translational Medical Sciences, University of Campania 'L. Vanvitelli', I-80138 Naples, Italy.
Iodice P; Division of Medical Oncology, 'San Giovanni Di Dio Hospital', ASL NA2NORD, I-80027 Naples, Italy.
Addeo R; Division of Medical Oncology, 'San Giovanni Di Dio Hospital', ASL NA2NORD, I-80027 Naples, Italy.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2019 Oct; Vol. 18 (4), pp. 3873-3879. Date of Electronic Publication: 2019 Aug 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 53

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies